Singapore grants interim approval for Moderna's bivalent Covid-19 booster vaccine

Singapore grants interim approval for Moderna's bivalent Covid-19 booster vaccine
PHOTO: Reuters

SINGAPORE - Singapore on Wednesday (Sept 14) granted interim authorisation for a bivalent Covid-19 booster vaccine made by Moderna, the government said in a statement.

The vaccine has been authorised for use as a booster shot in individuals aged 18 years and above who have received the primary series of Covid-19 vaccinations, the city-state's Health Sciences Authority said.

Moderna's bivalent vaccine contains mRNA designed to target two different coronavirus variants - the original variant from 2020 and the Omicron variant that was circulating widely last winter.

This website is best viewed using the latest versions of web browsers.